Marius Pharmaceuticals Expands Access of KYZATREX™ (testosterone undecanoate) to Department of Veterans Affairs (VA), Pledging Support for Proper Hormonal Balance Among Military Personnel
September 19, 2023 09:30 ET
|
Marius Pharmaceuticals LLC
RALEIGH, N.C., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a pharmaceutical company focused on developing innovative therapies for testosterone deficiency, is proud to announce the...
Pharmaceutical Intermediates Market Predicted to Reach USD 53.4 billion by 2031, Expanding at a CAGR of 6% Says, Transparency Market Research
August 29, 2023 04:53 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global pharmaceutical intermediates market is projected to flourish at a CAGR of 6%...
Marius Pharmaceuticals Supports AXYS 2023 Virtual Family Conference, Spotlighting KYZATREX™ for XY Chromosome Variations, such as Klinefelter’s Syndrome
June 20, 2023 08:30 ET
|
Marius Pharmaceuticals LLC
RALEIGH, N.C., June 20, 2023 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a patient-centric healthcare company specializing in therapies for hypogonadism or testosterone deficiency, announced today...
Marius Pharmaceuticals Announces Two Key Patents Related to KYZATREX™ in FDA Orange Book
June 09, 2023 10:00 ET
|
Marius Pharmaceuticals LLC
RALEIGH, N.C., June 09, 2023 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a patient-centric healthcare company focused on therapies designed for hypogonadism or testosterone deficiency, announced...
Endocrine Testing Market to reach USD 5.8 billion by 2032, Says Graphical Research Powered by GMI
June 05, 2023 06:00 ET
|
Graphical Research
Selbyville, Delaware, June 05, 2023 (GLOBE NEWSWIRE) -- Endocrine Testing Market size will be worth USD 5.8 billion by 2032. Growing advancements in endocrine testing are a prominent factor...
8.1% CAGR of Human Growth Hormone Market to Reach USD 7.3 Billion by 2032, Says Market.us Research Study
May 23, 2023 10:03 ET
|
Market.Us
New York, May 23, 2023 (GLOBE NEWSWIRE) -- The Human Growth Hormone Market in terms of revenue was estimated to be worth USD 3.4 Bn in 2022 and is poised to reach USD 7.3 bn by 2032, growing at a...
Esoteric Testing Market Size & Share | North America, Europe, & APAC Industry Forecasts 2028: Graphical Research
November 22, 2022 06:00 ET
|
Graphical Research
Pune, India, Nov. 22, 2022 (GLOBE NEWSWIRE) -- The global esoteric testing market size is predicted to witness remarkable growth during the forecast period, owing to rise in the frequency of rare...
Base Healthcare Launches Innovative Platform for Men with Testosterone Deficiency
October 18, 2022 08:00 ET
|
Base Healthcare
RALEIGH, N.C., Oct. 18, 2022 (GLOBE NEWSWIRE) -- Base Healthcare today announced the official launch of its subscription-based men’s virtual health platform, which focuses on foundational health and...
CORRECTION -- Marius Pharmaceuticals Receives FDA Approval of KYZATREX™, an Oral Testosterone Replacement Therapy
September 21, 2022 11:08 ET
|
Marius Pharmaceuticals LLC
RALEIGH, N.C., Sept. 21, 2022 (GLOBE NEWSWIRE) -- In a release issued under the same headline on August 2, 2022 by Marius Pharmaceuticals, please note that the correct number for reporting side...
Seraxis Announces Appointment of Chief Medical Officer, Dr. Paul Strumph
August 30, 2022 06:45 ET
|
Seraxis, Inc.
GERMANTOWN, Md., Aug. 30, 2022 (GLOBE NEWSWIRE) -- The regenerative medicine company Seraxis Inc. today announced the appointment of Paul Strumph, M.D. as Chief Medical Officer. Dr. Strumph is an...